Associate Professor, Medicine, Vanderbilt University School of Medicine
Hematology
Dr. Madan Jagasia, MD
|
|
Give Review
Madan Jagasia practices Hematology. He researched medicine at Seth G.S. Medical College. He has 1 awards "Regional Top Doctor". Dr. Madan Jagasia has written publications. He has 88 publications published with PubMed. The lastest publication is: 'Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase ...' He is registered with Medicare.
Publications
- Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenz...
- When Can You Discard Stem Cells?
- Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
- NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report.
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Wor...
- Referral to Transplant Center for Hematopoietic Cell Transplantation.
- Extracorporeal photopheresis as second-line treatment for Acute graft-versus-host disease: impact on six-month freedom from treatment failure.
- Association of severity of organ involvement with mortality and recurrent malignancy in patients with Chronic graft-versus-host disease.
- Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blo...
- PDGFRB-rearranged T-lymphoblastic Leukemia/lymphoma occurring with myeloid neoplasms: The missing link supporting a stem cell origin.
- Post-alloGraft pomalidomide and reversible hepatotoxicity.
- Impact of Age on Quality of Life, Functional Status and Survival in Patients with Chronic Graft-versus-Host Disease.
- Assessment of joint and fascia manifestations in Chronic graft-versus-host disease.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in Chronic gr...
- Increased BCR responsiveness in B cells from patients with Chronic GVHD.
- Investigator feedback about the 2005 NIH diagnostic and scoring criteria for Chronic GVHD.
- Expression of putative targets of immunotherapy in Acute myeloid leukemia and healthy tissues.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Chronic myelogenous Leukemia, version 1.2014.
- Optimizing Personalized Bone Marrow Testing Using an Evidence-Based, Interdisciplinary Team Approach.
- Geographic Distance Is Not Associated with Inferior Outcome When Using Long-Term Transplant Clinic Strategy.
- Six-month freedom from treatment failure is an important end point for Acute GVHD clinical trials.
- Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin Lymphoma.
- New allergies after cord blood transplantation.
- Analysis of Gastrointestinal and Hepatic Chronic Grant-versus-Host Disease Manifestations on Major Outcomes: A Chronic Grant-versus-Host Disease Consortium Study.
- Comorbidity burden in patients with Chronic GVHD.
- Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid refractory Acute GVHD: A multicenter comparative analysis.
- Expression of ñ4ò7 integrin on memory CD8(+) T cells at the presentation of Acute intestinal GVHD.
- Long-term follow-up of informal caregivers after allo-SCT: a Systematic review.
- Hand Grip Strength and 2-Minute Walk Test in Chronic Graft-versus-Host Disease Assessment: Analysis from the Chronic GVHD Consortium.
- Measurement of oral Chronic GVHD: results from the Chronic GVHD Consortium.
- Minimal residual Disease in myeloma: are we there yet?
- Tissue-specific regulatory T cells; biomarker for Acute graft-versus-host disease and survival.
- Time to Explore Preventive and Novel Therapies for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
- Endocrine complications in long-term survivors after allogeneic stem Cell transplant.
- Genetic variation in recipient B-Cell activating factor modulates phenotype of GVHD.
- Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood Grafts.
- Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic Syndrome from normal bone marrow.
- Classic and overlap Chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
- Peripheral T-cell Lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American Lymphoma classification.
- Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem Cell transplantation.
- Monitoring residual Myeloma: high-resolution serum/urine electrophoresis or marrow biopsy with immunohistochemical analysis?
- High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin Lymphoma: prognostic features and outcomes.
- Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic Syndromes: evidence for a role in apoptosis.
- Video-assisted talc pleurodesis in the management of pleural effusion secondary to continuous ambulatory peritoneal dialysis: a report of three cases.
- Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem Cell transplant: phase II study.
- Weekly irinotecan and cisplatin in advanced non-small cell lung Cancer: a multicenter phase II study.
- Outcome, toxicity profile and cost analysis of autologous stem Cell mobilization.
- Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
- Regulatory T cell expression of CLA or α(4)β(7) and skin or gut Acute GVHD outcomes.
- Age and cytogenetics as predictors of event free survival in patients with Acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as ...
- Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
- Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung Cancer: preliminary results comparing sequential phase ...
- High prevalence of metabolic Syndrome after allogeneic hematopoietic cell transplantation.
- Management of relapse after allo-SCT for AML and the role of second transplantation.
- Nilotinib is active in chronic and accelerated phase chronic myeloid Leukemia following failure of imatinib and dasatinib therapy.
- Diabetes mellitus after hematopoietic stem Cell transplantation.
- Time to consider HPV vaccination after allogeneic stem Cell transplantation.
- Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with Acute myeloid leukemia in first complete remission or with mye...
- NCCN clinical practice guidelines in oncology: chronic myelogenous Leukemia.
- NCCN clinical practice guidelines in oncology: multiple Myeloma.
- Gastric Graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation?
- Individual physician practice variation in hematopoietic Cell transplantation.
- Evaluating new treatment options for MDS.
- Incidence and outcome of Chronic graft-versus-host disease using National Institutes of Health consensus criteria.
- Pathology of Graft-versus-host disease in the gastrointestinal tract.
- Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
- Evaluation of mycophenolate mofetil for initial treatment of Chronic graft-versus-host disease.
- Progressive multifocal leukoencephalopathy in a patient with follicular Lymphoma treated with multiple courses of rituximab.
- Low-dose azacitidine after allogeneic stem cell transplantation for Acute leukemia.
- The graft-versus-Leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
- Variation in supportive care practices in hematopoietic Cell transplantation.
- Histology impacts the outcome of peripheral T-cell Lymphomas after high dose chemotherapy and stem cell transplant.
- Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester Disease.
- Erdheim-chester disease mimicking multiple meningiomas Syndrome.
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- Patient-reported quality of life is associated with severity of Chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic...
- Age and total-body irradiation in addition to corticosteroid dose are important risk factors for avascular necrosis of the bone.
- Comparison of short-term response and long-term outcomes after initial Systemic treatment of chronic graft-versus-host disease.
- Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.
- Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative n...
- Global and organ-specific Chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.
- Chronic myelogenous Leukemia. Clinical practice guidelines in oncology.
- Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic Syndrome pathogenesis.
- Risk factors for Acute GVHD and survival after hematopoietic cell transplantation.
Schools
University of MumbaiKing Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
Nassau County Med Center
Meth Hospital
Vanderbilt University Med Center
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Vanderbilt University -
Nassau University Medical Center -
Seth G.S. Medical College
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1043394166 | |
| NPPES Provider LastName | JAGASIA | |
| NPPES Provider FirstName | MADAN | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 313.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 4.79 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043394166 |
| Last Name Of The Provider | JAGASIA |
| First Name Of The Provider | MADAN |
| View All |
Similar Doctors
|
|
Dr. Claudio Mosse, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Ann Arildsen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth R. Hande, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Vandana G. Abramson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kent C. Shih, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sally J. York, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Graham T. Watson, MD |
|
|
Dr. James M. Pauff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ojiugo M. Iko, MB
This Doctor is OpenDoctor Recommended.
|